<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68832">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01922440</url>
  </required_header>
  <id_info>
    <org_study_id>PAR-R13-001</org_study_id>
    <nct_id>NCT01922440</nct_id>
  </id_info>
  <brief_title>PARADIGHM A Natural History Registry for Patients With Chronic Hypoparathyroidism</brief_title>
  <acronym>PARADIGHM</acronym>
  <official_title>PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Natural History Registry for Patients With Chronic Hypoparathyroidism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NPS Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NPS Pharmaceuticals</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, observational, natural history registry, designed to collect data on
      patients with chronic hypoparathyroidism. No study-defined procedures will be required, and
      if available, a select set of data will be collected at baseline and at least annually.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">June 2032</completion_date>
  <primary_completion_date type="Anticipated">June 2030</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <target_duration>17 Years</target_duration>
  <primary_outcome>
    <measure>Descriptive epidemiology of chronic hypoparathyroidism from baseline up to 17 years of follow-up</measure>
    <time_frame>From baseline up to 17 years of follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in chronic hypoparathyroidism clinical features from baseline up to 17 years of follow-up</measure>
    <time_frame>From baseline up to 17 years of follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in chronic hypoparathyroidism treatment from baseline up to 17 years of follow-up</measure>
    <time_frame>From baseline up to 17 years of follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in chronic hypoparathyroidism patients' health care resource use from baseline up to 17 years of follow-up</measure>
    <time_frame>From baseline up to 17 years of follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in chronic hypoparathyroidism patients' SF-36 health survey from baseline up to 17 years of follow-up</measure>
    <time_frame>From baseline up to 17 years of follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in chronic hypoparathyroidism patients' work productivity and activity impairment from baseline up to 17 years of follow-up</measure>
    <time_frame>From baseline up to 17 years of follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Chronic Hypoparathyroidism</condition>
  <arm_group>
    <arm_group_label>Chronic Hypoparathyroidism</arm_group_label>
    <description>n/a</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>None [Natural history registry]</intervention_name>
    <description>None</description>
    <arm_group_label>Chronic Hypoparathyroidism</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of any age or gender, with a diagnosis of chronic hypoparathyroidism before
        enrollment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A patient must meet all of the following criteria to be eligible for participation in the
        study:

          1. Patients of any age or gender, with a diagnosis of chronic hypoparathyroidism before
             enrollment.

             Chronic hypoparathyroidism, defined as one of the following:

               1. PTH value unequivocally low in the presence of  low serum calcium for at least 6
                  months prior to enrollment

               2. Post surgery (thyroid, parathyroid, neck) occurrence of hypoparathyroidism which
                  is currently treated with calcium/calcitriol supplements to maintain a
                  low/normal calcium (if absence of PTH level) for at least 6 months prior to
                  enrollment

               3. Post surgery (thyroid, parathyroid, neck), both serum PTH and calcium low for at
                  least 6 months post surgery and continues to enrollment

               4. Non-surgical hypoparathyroidism requiring calcium/calcitriol supplements to
                  maintain a low/normal calcium (if no PTH level available) for at least 6 months
                  prior to enrollment

          2. Signed informed consent and medical records release by the patient or a legally
             acceptable representative

        Exclusion Criteria:

        A patient who meets any of the following criteria is not eligible for participation in the
        study:

        1. Transient hypoparathyroidism within 6 months of enrollment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Bowlin, DO, MPH, PhD</last_name>
    <role>Study Director</role>
    <affiliation>NPS Pharmaceuticals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clinical Operations</last_name>
    <phone>908-450-5300</phone>
    <email>info@hypoparathyroidism.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bev McLaughlin</last_name>
      <phone>303-724-1026</phone>
      <email>Bev.Mclaughlin@UCDenver.edu</email>
    </contact>
    <investigator>
      <last_name>Michael McDermott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Alcantar</last_name>
      <phone>773-702-1197</phone>
      <email>Lalcanta@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Tamara Vokes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marian Hart</last_name>
      <phone>317-948-8346</phone>
      <email>Marihart@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Munro Peacock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Monis</last_name>
      <phone>617-726-3966</phone>
      <email>emonis@partners.org</email>
    </contact>
    <investigator>
      <last_name>Michael Mannstadt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamera Roberson</last_name>
      <phone>507-255-8621</phone>
      <email>Roberson.tamera@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Bart Clarke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Anderson</last_name>
      <phone>212-305-0573</phone>
      <email>LBA2131@Columbia.edu</email>
    </contact>
    <investigator>
      <last_name>John Bilezikian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrine Associates of Long Island, P.C.</name>
      <address>
        <city>Smithtown</city>
        <state>New York</state>
        <zip>11787</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Iannuzzi</last_name>
      <phone>631-265-5501</phone>
      <email>Islandendo@aol.com</email>
    </contact>
    <investigator>
      <last_name>Michael Shanik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Physicians Group Research Division</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bridget Recker</last_name>
      <phone>718-442-0300</phone>
      <email>research@upg.com</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Rothman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joslin Diabetes Center at SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Bulger</last_name>
      <phone>315-464-9008</phone>
      <email>BulgerJ@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Arnold Moses, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Physicians East, PA</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristie Daly-Barnes</last_name>
      <phone>252-413-6232</phone>
      <email>kbarnes@physicianseast.com</email>
    </contact>
    <investigator>
      <last_name>Mark Warren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Anaya</last_name>
      <phone>614-688-6257</phone>
      <email>amber.anaya@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Steven Ing, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrinology Associates of Armstrong</name>
      <address>
        <city>Indiana</city>
        <state>Pennsylvania</state>
        <zip>15701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samina Habibi</last_name>
      <phone>724-463-1048</phone>
    </contact>
    <investigator>
      <last_name>Mushtaq Syed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MaryJane Benton</last_name>
      <phone>215-590-4269</phone>
      <email>Benton@email.chop.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Levine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Salvatore</last_name>
      <email>Amanda.Salvatore@Jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Intekhab Ahmed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Carolina</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Whitmire</last_name>
      <phone>803-545-5430</phone>
      <email>Melanie.Whitmire@USCMED.SC.edu</email>
    </contact>
    <investigator>
      <last_name>Ali Rizvi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 2, 2014</lastchanged_date>
  <firstreceived_date>August 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Hypoparathyroidism</keyword>
  <keyword>Chronic HPTH</keyword>
  <keyword>Registry</keyword>
  <keyword>Natural History</keyword>
  <keyword>Observational study</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypoparathyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
